Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 545490, 4 pages
http://dx.doi.org/10.1155/2014/545490
Case Report

“Dancing Eye Syndrome” Secondary to Opsoclonus-Myoclonus Syndrome in Small-Cell Lung Cancer

1Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, AP-HM-Hôpital Nord, Chemin des Bourrely, 13326 Marseille Cedex 20, France
2Aix-Marseille University, 13005 Marseille, France
3Department of Respiratory Medicine, University Hospitals Galway, Galway, Ireland

Received 20 September 2013; Accepted 2 March 2014; Published 23 March 2014

Academic Editor: Hitoshi Okamura

Copyright © 2014 S. Laroumagne et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Dalmau and M. R. Rosenfeld, “Paraneoplastic syndromes of the CNS,” The Lancet Neurology, vol. 7, no. 4, pp. 327–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Musunuru and S. Kesari, “Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma,” Journal of Neuro-Oncology, vol. 90, no. 2, pp. 213–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. R. Berger and E. Mehari, “Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma,” Journal of Neuro-Oncology, vol. 41, no. 1, pp. 43–45, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Hauspy, A. Nevin, I. Harley et al., “Paraneoplastic syndrome in vaginal melanoma: a case report and review of the literature,” International Journal of Gynecological Cancer, vol. 17, no. 5, pp. 1159–1163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Kumar, W. A. Lajara-Nanson, and R. W. Neilson Jr., “Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma,” Journal of Neuro-Oncology, vol. 73, no. 1, pp. 43–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Dropcho and R. Payne, “Paraneoplastic opsoclonus-myoclonus: association with medullary thyroid carcinoma and review of the literature,” Archives of Neurology, vol. 43, no. 4, pp. 410–415, 1986. View at Google Scholar · View at Scopus
  7. S. J. Pittock, C. F. Lucchinetti, and V. A. Lennon, “Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments,” Annals of Neurology, vol. 53, no. 5, pp. 580–587, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Bataller, M. R. Rosenfeld, F. Graus, J. J. Vilchez, N.-K. V. Cheung, and J. Dalmau, “Autoantigen diversity in the opsoclonus-myoclonus syndrome,” Annals of Neurology, vol. 53, no. 3, pp. 347–353, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Nadal, J. Bruna, M. O. de Olza, M. Antonio, and F. Cardenal, “Paraneoplastic opsoclonus-myoclonus syndrome as a new and single manifestation of relapsing disease in a patient with small cell lung cancer,” Journal of Thoracic Oncology, vol. 6, no. 5, pp. 968–969, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Helmchen, H. Rambold, A. Sprenger, C. Erdmann, and F. Binkofski, “Cerebellar activation in opsoclonus: an fMRI study,” Neurology, vol. 61, no. 3, pp. 412–415, 2003. View at Google Scholar · View at Scopus
  11. K. M. Vandervest and M. I. Schwarz, “A 76-year-old woman with acute CNS symptoms and pulmonary nodules,” Chest, vol. 136, no. 6, pp. 1686–1689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Saiz, Y. Blanco, L. Sabater et al., “Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association,” Brain, vol. 131, no. 10, pp. 2553–2563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. McHugh, B. Murray, R. Renganathan, S. Connolly, and T. Lynch, “GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma,” Movement Disorders, vol. 22, no. 9, pp. 1343–1346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Scheid, T. Lincke, R. Voltz, D. Y. von Cramon, and O. Sabri, “Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis,” Archives of Neurology, vol. 61, no. 11, pp. 1785–1789, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Giometto, G. C. Marchiori, P. Nicolao et al., “Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system,” Neuropathology and Applied Neurobiology, vol. 23, no. 6, pp. 468–474, 1997. View at Google Scholar
  16. J. Verschnuren, L. Chuang, M. K. Rosenblum et al., “Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration,” Acta Neuropathologica, vol. 91, no. 5, pp. 519–525, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Vedeler, J. C. Antoine, B. Giometto et al., “Management of paraneoplastic neurological syndromes: report of an EFNS Task Force,” European Journal of Neurology, vol. 13, no. 7, pp. 682–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Titulaera, R. Soffiettib, J. Dalmauc et al., “Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force,” European Journal of Neurology, vol. 18, no. 1, p. 19-e3, 2011. View at Google Scholar